HansBiomed Corporation (KOSDAQ: 042520)
South Korea
· Delayed Price · Currency is KRW 8,890.00
+40.00 (0.45%)
Dec 20, 2024, 9:00 AM KST
HansBiomed Income Statement
Financials in millions KRW. Fiscal year is October - September.
Millions KRW. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 | 2018 - 2014 |
| Operating Revenue | 80,639 | 78,032 | 74,459 | 59,098 | 80,098 | 66,991 | Upgrade
|
| Other Revenue | -0 | -0 | -0 | - | - | - | Upgrade
|
| Revenue | 80,639 | 78,032 | 74,459 | 59,098 | 80,098 | 66,991 | Upgrade
|
| Revenue Growth (YoY) | 2.64% | 4.80% | 25.99% | -26.22% | 19.57% | 29.46% | Upgrade
|
| Cost of Revenue | 30,884 | 32,909 | 28,776 | 29,869 | 37,583 | 26,843 | Upgrade
|
| Gross Profit | 49,754 | 45,123 | 45,683 | 29,229 | 42,515 | 40,148 | Upgrade
|
| Selling, General & Admin | 43,170 | 40,716 | 35,876 | 35,297 | 37,982 | 22,409 | Upgrade
|
| Research & Development | 4,464 | 5,597 | 5,658 | 7,148 | 5,511 | 4,038 | Upgrade
|
| Other Operating Expenses | 1,277 | 804.27 | 733.33 | 1,405 | 634.14 | 649.84 | Upgrade
|
| Operating Expenses | 52,084 | 49,278 | 44,427 | 49,007 | 45,922 | 27,576 | Upgrade
|
| Operating Income | -2,330 | -4,155 | 1,256 | -19,778 | -3,407 | 12,572 | Upgrade
|
| Interest Expense | -2,325 | -5,523 | -6,282 | -3,498 | -1,366 | -608.21 | Upgrade
|
| Interest & Investment Income | 37.13 | 109.3 | 243.24 | 137.62 | 166.55 | 78.12 | Upgrade
|
| Earnings From Equity Investments | -1,655 | -1,857 | -2,644 | 14.09 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 272.16 | -198.83 | 1,852 | 173.91 | -73.16 | 843.59 | Upgrade
|
| Other Non Operating Income (Expenses) | -2,366 | -11,524 | 9,075 | -2,141 | -2,892 | 230.79 | Upgrade
|
| EBT Excluding Unusual Items | -8,367 | -23,149 | 3,500 | -25,092 | -7,572 | 13,117 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | -7.48 | 24.34 | Upgrade
|
| Gain (Loss) on Sale of Assets | -91.91 | -16.98 | 1.6 | 54.82 | -2.39 | -20.56 | Upgrade
|
| Asset Writedown | -361.76 | -366.16 | - | - | -9,118 | -1,636 | Upgrade
|
| Other Unusual Items | - | - | - | 3,420 | - | - | Upgrade
|
| Pretax Income | -8,821 | -23,532 | 3,501 | -21,617 | -16,700 | 11,484 | Upgrade
|
| Income Tax Expense | 1,690 | 559.59 | -1,421 | 508.78 | 1,471 | 1,974 | Upgrade
|
| Earnings From Continuing Operations | -10,511 | -24,092 | 4,923 | -22,126 | -18,171 | 9,511 | Upgrade
|
| Minority Interest in Earnings | 1,019 | 1,047 | 1,224 | 3,837 | 330.63 | 439.74 | Upgrade
|
| Net Income | -9,493 | -23,045 | 6,147 | -18,289 | -17,840 | 9,951 | Upgrade
|
| Net Income to Common | -9,493 | -23,045 | 6,147 | -18,289 | -17,840 | 9,951 | Upgrade
|
| Net Income Growth | - | - | - | - | - | 139.23% | Upgrade
|
| Shares Outstanding (Basic) | 13 | 11 | 10 | 10 | 10 | 10 | Upgrade
|
| Shares Outstanding (Diluted) | 13 | 11 | 13 | 10 | 10 | 10 | Upgrade
|
| Shares Change (YoY) | 22.39% | -18.41% | 31.21% | 1.48% | 0.37% | 1.98% | Upgrade
|
| EPS (Basic) | -752.85 | -2150.23 | 624.45 | -1826.69 | -1808.34 | 1012.36 | Upgrade
|
| EPS (Diluted) | -752.85 | -2150.23 | 180.37 | -1827.00 | -1808.34 | 1012.00 | Upgrade
|
| EPS Growth | - | - | - | - | - | 134.50% | Upgrade
|
| Free Cash Flow | -813.21 | -5,670 | -8,256 | -19,535 | -1,295 | -7,850 | Upgrade
|
| Free Cash Flow Per Share | -64.49 | -529.02 | -628.48 | -1951.22 | -131.27 | -798.68 | Upgrade
|
| Dividend Per Share | - | - | - | - | - | 120.000 | Upgrade
|
| Dividend Growth | - | - | - | - | - | 20.00% | Upgrade
|
| Gross Margin | 61.70% | 57.83% | 61.35% | 49.46% | 53.08% | 59.93% | Upgrade
|
| Operating Margin | -2.89% | -5.32% | 1.69% | -33.47% | -4.25% | 18.77% | Upgrade
|
| Profit Margin | -11.77% | -29.53% | 8.26% | -30.95% | -22.27% | 14.85% | Upgrade
|
| Free Cash Flow Margin | -1.01% | -7.27% | -11.09% | -33.06% | -1.62% | -11.72% | Upgrade
|
| EBITDA | 2,997 | 1,043 | 6,158 | -14,993 | 206.09 | 14,326 | Upgrade
|
| EBITDA Margin | 3.72% | 1.34% | 8.27% | -25.37% | 0.26% | 21.39% | Upgrade
|
| D&A For EBITDA | 5,327 | 5,198 | 4,902 | 4,785 | 3,613 | 1,754 | Upgrade
|
| EBIT | -2,330 | -4,155 | 1,256 | -19,778 | -3,407 | 12,572 | Upgrade
|
| EBIT Margin | -2.89% | -5.32% | 1.69% | -33.47% | -4.25% | 18.77% | Upgrade
|
| Effective Tax Rate | - | - | - | - | - | 17.18% | Upgrade
|
| Advertising Expenses | - | 4,411 | 4,419 | 2,150 | 3,472 | 2,610 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.